Martin Zack Selected Research

Gambling (Pathological Gambling)

1/2023	Priming effects of a slot machine game and amphetamine on probabilistic risk-taking in people with gambling disorder and healthy controls.
1/2019	Impulsivity moderates the effects of dopamine D2 and mixed D1-D2 antagonists in individuals with gambling disorder.
11/2016	Effects of High Frequency Repeated Transcranial Magnetic Stimulation and Continuous Theta Burst Stimulation on Gambling Reinforcement, Delay Discounting, and Stroop Interference in Men with Pathological Gambling.
9/2015	Differential cardiovascular and hypothalamic pituitary response to amphetamine in male pathological gamblers versus healthy controls.
1/2014	Chronic exposure to a gambling-like schedule of reward predictive stimuli can promote sensitization to amphetamine in rats.
5/2013	The D2/3 dopamine receptor in pathological gambling: a positron emission tomography study with [11C]-(+)-propyl-hexahydro-naphtho-oxazin and [11C]raclopride.
1/2013	Opioid and dopamine mediation of gambling responses in recreational gamblers.
7/2011	Haloperidol modifies instrumental aspects of slot machine gambling in pathological gamblers and healthy controls.
1/2009	Parallel roles for dopamine in pathological gambling and psychostimulant addiction.
8/2007	A D2 antagonist enhances the rewarding and priming effects of a gambling episode in pathological gamblers.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Martin Zack Research Topics

Disease

11	Gambling (Pathological Gambling) 01/2023 - 01/2004
2	Parkinson Disease (Parkinson's Disease) 02/2015 - 01/2009
1	Schizophrenia (Dementia Praecox) 01/2018
1	Disruptive, Impulse Control, and Conduct Disorders (Kleptomania) 02/2015
1	Tobacco Use Disorder (Nicotine Dependence) 10/2013

Drug/Important Bio-Agent (IBA)

5	Amphetamine (Amfetamine)FDA LinkGeneric 01/2023 - 01/2004
5	Dopamine (Intropin)FDA LinkGeneric 01/2019 - 08/2007
2	Dopamine Receptors (Dopamine Receptor)IBA 02/2015 - 05/2013
2	Haloperidol (Haldol)FDA LinkGeneric 07/2011 - 08/2007
1	Dextroamphetamine (Dexedrine)FDA LinkGeneric 01/2023
1	Varenicline (Chantix)FDA Link 01/2018
1	Dopamine Agonists (Dopamine Agonist)IBA 02/2015
1	Nicotine FDA Link 10/2013
1	naxagolideIBA 05/2013
1	RacloprideIBA 05/2013
1	Opioid Analgesics (Opioids)IBA 01/2013
1	Dopamine D2 Receptor AntagonistsIBA 08/2007

Therapy/Procedure

1	Transcranial Magnetic Stimulation 11/2016